Glycosylated haemoglobin in renal failure

Area of Science:

• Nephrology
• Endocrinology
• Clinical Chemistry

Background:

• Glycosylated hemoglobin (HbA1c) is a key marker for long-term glycemic control.
• Renal function can influence HbA1c levels, but the direct impact of renal failure requires further elucidation.

Purpose of the Study:

• To investigate the effect of renal failure and intermittent hemodialysis on HbA1c levels.
• To compare HbA1c in patients with normal renal function, renal failure, and those undergoing dialysis.

Main Methods:

• Measurement of HbA1c levels in three groups: normal renal function, renal failure, and intermittent hemodialysis patients.
• Correlation analysis between HbA1c and fasting blood glucose was performed.
• HbA1c levels were monitored before and after 3 months of dialysis.

Main Results:

• Patients with renal failure showed significantly higher mean HbA1c (6.6%) compared to controls (4.7%).
• Patients on intermittent hemodialysis had elevated mean HbA1c (6.3%), which did not decrease after 3 months of dialysis.
• No correlation between HbA1c and fasting blood glucose was observed in patients with renal failure or on dialysis.

Conclusions:

• Renal failure is independently associated with increased HbA1c levels.
• Elevated HbA1c in renal failure patients may not solely reflect glycemic control but also the impact of kidney disease.
• Intermittent hemodialysis does not normalize elevated HbA1c levels in patients with renal failure.